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058 The Journal of Thoracic and Cardackground: In vivo comparison of the performance of heart valve prostheses is
onfounded by several factors, such as different nominal size, patients’ character-
stics and hemodynamics, surgical techniques, and study design. The aim of this
tudy was to compare the in vitro hydrodynamic performances of 5 different tissue
alves that would fit a 21-mm-diameter valve holder of the Sheffield pulse duplicator.
ethods: Three samples of 5 supra-annular production-quality tissue valves, in-
luding the sewing ring cuffs, were tested in the aortic chamber of the Sheffield
ulse duplicator. The prostheses fitting a 21-mm valve holder, which is comparable
ith a 21-mm aortic annulus, were as follows: 20-mm Sorin Soprano, 21-mm
arpentier-Edwards Magna, 21-mm SJM-Biocor-Epic-Supra, 21-mm Medtronic
osaic, and 23-mm Mitroflow. The tests were carried out at a fixed pulse rate (70
eats/min) and at increasing cardiac outputs of 2, 4, 5, and 7 L/min. Each valve was
ested 10 times for each different cardiac output. This resulted in a total of 40 tests
or each valve and 120 tests for each valve model. Forward flow pressure decrease,
ffective orifice area, stroke work loss, and total regurgitant, closing, and leakage
olumes were recorded while the valve operated under each cardiac output.
esults: Pericardial valves showed significantly lower transvalvular gradients than
orcine valves, unlike the SJM-Biocor-Epic-Supra valve at 2 L/min of cardiac
utput. Although the Carpentier-Edwards Magna valve provided the best perfor-
ance at 2 and 4 L/min, the Mitroflow valve exhibited the lowest mean and peak
radients at 5 to 7 L/min. Total regurgitant and leakage volumes were higher for the
arpentier-Edwards Magna valve and lower for the SJM-Biocor-Epic-Supra and
itroflow valves. Between 2 and 4 L/min, the calculated effective orifice area and
troke work loss were better for the Carpentier-Edwards Magna valve, whereas
etween 5 and 7 L/min, they were significantly superior with the Mitroflow
rosthesis. Among the porcine bioprostheses, the SJM-Biocor-Epic-Supra valve
howed significantly better results when compared with the Medtronic Mosaic valve
t each cardiac output.
onclusion: Assuming that the valve holder is comparable with a defined aortic
nnulus of 21 mm in which a spread of supra-annular tissue valves could be fitted,
his hydrodynamic evaluation model allows comparison of the efficiency of cur-
ently available bioprostheses with a definite tissue annulus diameter. Pericardial
alves exhibited the best performances, and the Mitroflow valve showed the lowest
radients and stroke work loss at increasing cardiac output.
he task of aortic valve surgery is to eliminate left ventricular outflow tract
obstruction, allowing regression of left ventricular hypertrophy.1-4 Accord-
ing to these principles, it is crucial to select the optimal stented valve
ubstitute with the lowest residual gradients. Additional options are the use of
tentless valves or annulus enlargement. However, in these cases the increased
perative risk must be weighed against the hemodynamic benefits.5,6 Stentless valve
iovascular Surgery ● May 2006
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A
CDmplantation and annulus-enlarging procedures are more de-
anding techniques.5,7 Hence it seems logical to implant
upra-annular tissue valves, which are placed on top of the
ortic annulus and can guarantee the advantages of the
tented valve (easier and less time-consuming implantation).8
edtronic Mosaic (MM), Carpentier-Edwards Magna (CEM),
orin Soprano (SS), SJM-Biocor-Epic-Supra (SJME), and
itroflow (MF) valves belong to this latter category of
rostheses. Nevertheless, for these prostheses, the nominal
alve size is not uniform, and therefore the hemodynamic
omparison is somehow misleading.9 Moreover, the in vivo
tudies are further penalized by patients’ differences, selec-
ion biases, and variability in suturing techniques.10 After
ur previous study with mechanical prostheses, we com-
ared the hydrodynamic performances of these 5 different
odels of supra-annular pericardial and porcine bioprosthe-
es, selecting for each model the tissue annulus diameter
hat could fit a 21-mm-diameter valve holder of a Sheffield
ulse duplicator (SPD), regardless of the industry-labeled
alve size.
aterials and Methods
he SPD is a system designed to perform pulsatile hydrodynamic
esting of prosthetic heart valves by means of continuous measure-
ent of flow and transvalvular pressure gradients. The system has
een previously described in detail.11,12
Production-quality bioprostheses, including the sewing ring
uffs, were tested in the aortic chamber of the SPD. The pulse
uplicator holder is composed of 2 O-rings, and the prosthesis is
ecured between these rings (Figure 1).
To allow a meaningful comparison regardless of industry-
abeled valve size, we tested the supra-annular tissue valves with
tissue annulus diameter that could be fitted in a 21-mm pulse
uplicator ring. Because of the supra-annular configuration, the
pposite ring to fix the valve measured 23 mm. Measured dimen-
ions and labeling sizes of the tested valves are reported in Table 1.
he valves and the holder were sealed before testing. The sizes of
he tested valves were as follows: 20 mm for the SS valve; 21 mm
or the SJME, CEM, and MM valves; and 23 mm for the MF valve.
he valves were tested according to standard protocols previously
eported.12-14
Three production-quality samples of each tissue valve were
Abbreviations and Acronyms
CEM  Carpentier-Edwards Magna
CO  cardiac output
EOA  effective orifice area
MF Mitroflow
MM Medtronic Mosaic
SPD  Sheffield pulse duplicator
SJME SJM-Biocor-Epic-Supra
SS  Sorin Sopranoested. The tests were carried out at a single pulse rate (70 beats/ a
The Journal of Thoracicin), with a cardiac output (CO) of 2, 4, 5, and 7 L/min according
o ISO584015 and the US Food and Drug Administration “Re-
lacement heart valve guidance” protocol.16 For the aortic tests,
he transducers are located 30 mm from the prosthesis (upstream)
igure 1. The supra-annular tissue valve is placed on top of the
ortic annulus, with pledgets usually placed in a subannular
ashion. In our model we considered the top of the aortic annulus
o be the top of the first mounting ring. We compared the pros-
heses with the larger tissue annulus diameters that could be
uperimposed to the first mounting ring (21 mm). No larger label
ize of each valve could be used because in each case a valve
ith a greater size would have had a greater encumbrance
sewing ring >28 mm), limiting their use in a hypothetical small
ortic annulus. With the tissue annulus diameter and the sewing
ing diameter larger than the internal diameter, to fix the valve at
he top of the first mounting ring as it occurs in the supra-aortic
osition, we used a second thinner mounting ring larger than the
rst one (23 mm), allowing the slipping through the ring of
ommissural posts and of the collar of the sewing cuff, without
pplying any force and without deforming the stent, as it should
e in vivo when the valve is sutured with subannular pledgeted
utures inside the sinus portion of the ascending aorta. Therefore
he results of this study are not confounded by the suture
echnique.nd 100 mm from the valve (downstream), with the tip of the
and Cardiovascular Surgery ● Volume 131, Number 5 1059
t
c
T
e
s
f
f
l
v
c
s
s
u
v
l
t
b

c
R
M
T
n
a
t
t
m
t
r
s
s
n
d
a
c
a
s
v
d
e
l
d
a
t
M
w
o
w
t
o
(
S
h
v
S
a
C
b
s
I
T
p
T
P
T
r
l
v
t
d
T
M
S
C
M
S
M
M
Surgery for Acquired Cardiovascular Disease Gerosa et al
1
A
CDransducer adjusted to lie flush with the inner wall of the flow
hamber. Each valve was tested 10 times at each different CO.
his resulted in a total of 40 tests for each valve and 120 tests for
ach valve model. All the tests and the acquisition of data (mean and
tandard deviations) were performed as previously described.12 The
ollowing parameters were determined for each cardiac cycle: (1)
orward flow pressure decrease (P); (2) closing volume (in mil-
iliters); (3) leakage volume (in milliliters); (4) total regurgitant
olume (in milliliters); (5) effective orifice area (EOA; in square
entimeters; EOA  RMS systolic flow rate[mL/s]/[51.6·Root
quare {Mean systolic pressure difference/1.0085}]); and (6)
troke work loss (in percentage).
Forward flow pressure decrease, closing volume, leakage vol-
me, total regurgitant volume, and EOA were calculated as pre-
iously published by Walker and colleagues.13 The stroke work
oss was calculated as the ratio of the mean systolic aortic pressure
o the mean systolic ventricular pressure, as previously published
y Voelker and associates.14 All data were expressed as means
standard deviation. The 2 test was used for statistical
omparison.
esults
easurements for All Valve Models
able 1 shows the measurements for all valve models by
ominal size. The value is a mean measurement made with
very professional ruler. Two different independent inves-
igators measured all the prostheses, and measurements are
he expression of a mean value of 3 different valves for each
odel, including the maximum and minimum values ob-
ained for each valve. We avoided compressing the sewing
ing or stretching the stent when we measured the prosthe-
es. Measuring the internal orifice diameter, we also con-
idered the thickness of the tissue composing the cusps and
ot only the distance in between fabric to fabric.
Internal orifice diameter. The largest internal orifice
iameter was observed for the SS, MF, and CEM valves,
nd the smallest was observed for the MM valve. When
ompared with nominal size, the actual internal orifice di-
meter was 4 mm smaller for the MF and MM valves, 3 mm
maller for the SJME valve, 2 mm smaller for the CEM
ABLE 1. Geometrics of the tested valves
odel
Label size
(mm)
Internal diameter
(mm)
Tissue-annulus
diameter (mm)
orin Soprano 20 19 0.3 (19.8) 23 0.4 (23)
arpentier-Edwards
Magna
21 19 0.4 (20) 22 0.4 (21)
itroflow 23 19 0.3 (19) 22.5 0.4 (22.6
JM-Biocor-Epic-
Supra
21 18 0.5 (20.8) 22 0.4 (21)
edtronic Mosaic 21 17 0.3 (18.5) 21 0.2 (21)
anufacturers’ values are shown in parentheses.alve, and 1 mm smaller for the SS valve. L
060 The Journal of Thoracic and Cardiovascular Surgery ● MaTissue annulus diameter. The largest tissue annulus
iameter was observed for the SS valve, whereas the small-
st was observed for the MM valve. The CEM valve showed
ess thickness of the complex tissue stent fabric because the
ifference between internal annulus diameter versus tissue
nnulus diameter was 3 mm. The difference was 3.5 mm for
he MF valve and 4.5 mm for the SS valve. The SJME and
M valves showed a difference of 4 mm in both cases.
Sewing ring diameter. The largest sewing ring diameter
as observed for the SS valve, whereas the smallest was
bserved for the MF and MM valves. The thinnest valve
as the MF valve because the smallest difference between
he sewing ring diameter and internal orifice diameter was
bserved in this model (7 mm), followed by the CEM valve
7.5 mm), the MM and SS valves (9 mm), and finally the
JME valve (9.5 mm).
Height and aortic protrusion. The MF valve was the
ighest valve (15 mm), and because of the flat profile in this
alve, the aortic protrusion was equal to the height. The
JME valve was the valve with the lowest profile (11 mm)
nd with the smallest aortic protrusion (14 mm).
Height and coronary sinus protrusion. The MF and
EM valves showed the shortest difference between the
ase of the valve and the maximal height of the coronary
inus. The SS valve showed the highest profile.
n Vitro Performances
he obtained mean values and standard deviations are ex-
ressed according to the 4 COs adopted and are reported in
able 2.
ressure Differences
he mean and peak pressure differences for each CO are
eported in Figure 2. Pericardial valves showed significantly
ower gradients than porcine valves, unlike for the SJME
alve at 2 L/min. The CEM valve at 2 and 4 L/min showed
he lower pressure difference, although not significantly
ifferent than the MF and SS valves. At increasing CO (5-7
Sewing ring
diameter (mm) Height (mm)
Aortic
protrusion (mm)
Coronary-sinus
protrusion
(mm)
28 0.5 14.5 0.5 14.5 0.5 0.6  0.1
6.5 0.5 (26) 15 0.3 (15) 13 0.4 0.4  0.1
26 0.5 (26.2) 15 0.3 (13.7) 15 0.3 0.4  0.1
7.5 0.3 14 0.4 (13) 11 0.4 (11) 0.5  0.1
26 0.3 (27) 15 0.4 (15) 12.5 0.4 (12) 0.5 0.12
)
2/min), the MF valve significantly increased its performances,
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A
CDhowing the lowest pressure differences in comparison with
oth the CEM and SS valves (P  .05). The SJME valve at
ach CO had shown significantly lower pressure differences
han the MM valve (P  .05).
egurgitant Volumes
he observed total regurgitant volumes are reported in
igure E1. The SJME valve showed the lowest regurgi-
ant volume (3 mL), which was significantly smaller for
ach CO when compared with that obtained with the
EM and MM valves (P  .005). On the contrary, the
EM valve showed the significantly highest regurgitant
olume (12 mL) in comparison with the other valves (P 
0005). The results for the SJME, SS, and MF valves were
omparable.
losure Volume
ll the tested valves showed a decreasing closure volume as
O increased. The highest value was observed with the
EM prosthesis (P  .005). The SJME valve showed the
owest closure volume at each CO, and the results were
ignificantly different in comparison with all the other tested
alves, except the MF valve (P  .05).
eakage Volume
he grade of the leakage volume for each tested valve is
eported in Figure E2. The MF valve showed the lowest
eakage volume, which was significantly smaller for each
ABLE 2. Hydrodynamic performances of the tested valves
odel CO (L/min) MSPD (mm Hg) PSPD
arpentier-Edwards Magna,
21 mm
2.00 6.75 1.44 12.5
4.00 9.38 1.3 21.1
5.00 13.23 0.67 30.9
7.00 20.85 0.5 38.0
orin Soprano, 20 mm 2.00 7.22 2.3 14.4
4.00 11.07 2.3 23.
5.00 13.7 2.1 28.
7.00 20.42 2.9 36.
itroflow, 23 mm 2.00 7.10 1.6 1
4.00 9.66 1.7 22.6
5.00 11.64 1.9 27.3
7.00 16.89 2.6 31.4
JM-Biocor-Epic-Supra,
21 mm
2.00 7.41 1.8 13.
4.00 13.06 1.5 24.
5.00 17.37 1.8 36.
7.00 27.5 1.37 50.
edtronic Mosaic, 21 mm 2.00 9.65 0.7 15.9
4.00 19.5 0.35 33.9
5.00 25.8 0.23 52.
7.00 39.98 0.57 70.
O, Cardiac output; MSPD, mean systolic pressure difference; PSPD, peak
olume; EOA, effective orifice area; SWL, stroke work loss.O when compared with that obtained with the CEM and c
The Journal of ThoracicM valves (P  .0005). The leakage volumes observed
ith the SJME and SS valves were comparable with that of
he MF valve. The highest leakage volume was observed
ith the CEM valve. All the tested tissue valves showed a
eakage volume greater than the closure volume.
ffective Orifice Area
he calculated EOAs for all valves are reported in Figure
3. The EOA observed with the CEM valve was compara-
le with those observed with the MF and SS valves (P 
1), but the MF valve had a significantly higher EOA at 7
/min than the other 2 pericardial valves. The CEM valve
howed also higher EOA than the SS valve at 5 L/min,
lthough this was not significant (P .69). The SJME valve
t 2 L/min CO showed comparable results with the pericar-
ial valves, whereas the difference became significant at 4, 5,
nd 7 L/min. The MM valve showed a significantly lowest
OA at each CO (P  .005). In all the tested valves, the
alculated EOA was larger at increasing CO.
troke Work Loss
he calculated stroke work loss values for each tested valve are
isted in Figure E4. The stroke work loss profile for each valve
as similar, increasing concurrently with increasing CO. The
esults obtained at 2 L/min were comparable for all the peri-
ardial prostheses and for the SJME valve. At 4 to 5 and 7
/min, the porcine valves showed significantly worse values in
an value  SD) at COs of 2, 4, 5, and 7 L/min
Hg) TRV (mL) VLV (mL) EOA (cm2) SWL (%)
12.64 1.5 9.72  1 0.79 0.09 6.86 1.2
.7 12.92 1.3 11.61  1.3 1.38 0.1 9.71  0.88
.5 12.83 0.9 11.68  0.9 1.48 0.03 13.92 0.7
.7 12.07 0.73 11.10 0.76 1.59 0.01 20.95 0.83
.1 3.42 1.7 2.32 1.3 0.74 0.13 8.70 2.6
.9 3.13 1.4 2.24  1.18 1.29 0.15 12.6 2.8
.6 3.4 1.9 2.5  1.6 1.46 0.14 15.2  2.3
.1 2.76 1.6 2.1  1.37 1.63 0.14 20.99 1.63
.4 3.05 1.5 1.7  0.99 0.73  0.09 8.63  2.2
.57 2.95 0.81 1.35 0.5 1.35 0.14 11.73  2.83
.4 2.76 0.61 1.57 0.23 1.57 0.17 13.83  3.16
2.73 0.57 1.48 0.24 1.79 0.17 17.93  2.74
.32 2.29 1 1.84 1 0.76 0.14 9.36 2.7
.3 2.66 1 2.15 1.15 1.23 0.11 14.75  2.16
.6 2.78 0.98 2.29  1 1.34 0.12 19.1 2.8
.8 2.31 1.2 1.99 1.2 1.44 0.12 27.13  2.5
8.05 0.9 6.35 0.67 0.65 0.02 11.25  0.43
.4 7.5 0.67 6.72 0.64 0.99 0.008 20.94 0.24
.86 7.26 1.37 6.72 1.34 1.09 0.005 26  0.27
9.2 1.8 8.7 3.7 1.17 0.005 34.7 0.24
lic pressure difference; TRV, total regurgitant volume; VLV, valve leakage(me
(mm
1 2
7 1
6 2
4 1
6 2
1  2
7 3
1  6
5  1
5 0
7 1
7 2
5 2
9  2
2  4
5 3
1 2
4 1
4 0
2 3
systoomparison with the pericardial bioprostheses. At 2 and 4
and Cardiovascular Surgery ● Volume 131, Number 5 1061
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A
CD/min, the CEM valve showed the best performances, which,
owever, were comparable with those obtained with the SS
nd MF valves. Between 5 and 7 L/min, the MF valve was the
est performing valve, showing the lowest stroke work loss,
hich proved to be statistically significant when compared
ith both the CEM and SS valves at 7 L/min (P  .05).
iscussion
ll valve substitutes, because of design, size, material, and
mplantation technique, leave some kind of residual steno-
is.1,17 Recent studies have demonstrated the importance of
voiding severe mismatch,4 and hence the choice of valve
rostheses and implantation techniques become of para-
ount importance.
The transvalvular gradient is dependent on flow and EOA,
nd with the EOA clearly related to the internal diameter of
he prosthesis, the supra-annular prostheses have been de-
igned with the intention of having a greater internal diam-
igure 2. A, Mean systolic pressure difference; B, peak systolic
ressure difference. CE, Carpentier-Edwards.ter and a greater geometric orifice area within a defined t
062 The Journal of Thoracic and Cardiovascular Surgery ● Maissue annulus dimension.10 However, comparison between
ifferent tissue valves is always complicated and sometimes
isleading.
It is therefore necessary to compare the performances of
hese prostheses in relation to the actual tissue annulus
iameter and not on the basis of industry-labeled valve size
o obtain accurate and clinically relevant data on the hydro-
ynamic performances of different valve types. Therefore
e designed an in vitro study fitting in the pulse duplicator
he largest tissue annulus diameter of each different valve
odel able to superimpose the 21-mm valve holder ring,
hich would mimic a 21-mm aortic annulus.
omparison of Actual Sizer and Valve Dimensions
ersus Labeled Diameters
ur findings parallel those of previous authors9 because in
ll the measured valves there was evidence that the actual
ize and valve dimensions vary considerably from the la-
eled diameters. Only for the MM valve was the label size
quivalent to the tissue annulus diameter. On the contrary,
s previously observed,10 to give the surgeon a quick idea
bout the appropriate valve, the labeled size of the valve
hould reflect the tissue annulus diameter. We compared
upra-annular tissue valves with a tissue annulus diameter
anging between 21 and 23 mm. In all these prostheses,
here was a large variability between internal orifice diam-
ter and sewing ring diameter, between internal orifice
iameter and tissue annulus diameter, and between tissue
nnulus diameter and sewing ring diameter. We found it
mpossible to test larger prostheses in label size than those
ested because larger size would mean a larger sewing ring
28 mm) and higher profile, increasing the prosthesis
ncumbrance in the sinus portion of the aorta.
We sought to address these limitations by selecting a
elatively homogeneous group of valves, using those with
he largest tissue annulus diameter that could be superim-
osed in a definite pulse duplicator ring without forcing the
nsertion to avoid stent modification because in our experi-
nce the distortion of the normal planar geometry of the
ericardial prosthesis, induced by fixation with a second not
dequate ring, resulted in failure of adequate central leaflet
oaptation. This issue was already observed in vivo by other
uthors.18 The MM valve was the sole valve with a tissue
nnulus diameter smaller than 22 mm; nonetheless, an up-
izing was impossible. A modification of the cuff has been
ntroduced on the new MM valve, namely the Mosaic Ultra,
nd further studies will be required on this new model. The
alves with the more advantageous ratio between internal
rifice diameter versus tissue annulus diameter versus sewing
ing diameter were the MF and CEM valves. The valve with
he lowest height and aortic protrusion was the SJME valve. At
certain extent, this means that for this model, the implantationechnique should be more comfortable. The valves with the
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A
CDowest coronary sinus protrusion were the MF and CEM
alves, further justifying their easier implantation.
n Vitro Comparison of Hemodynamic Performances
f Different Tissue Valves
recent prospective randomized study has been published by
ichinger and coworkers.19 The authors showed a significant
emodynamic superiority of the bovine tissue valves compared
ith the porcine bioprostheses (Carpentier-Edwards Perimount
ersus MM valves). Moreover, Eichinger and coworkers19
nfer that sometimes an upsizing of the MM valve is possible
ecause the sewing ring diameter of the latter is smaller than
hat of the Carpentier-Edwards Perimount valve. Our in vitro
esults show that this upsizing is not possible for the MM
alve versus the CEM valve. Further studies will address
his issue with the new MM Ultra valve. Seitelberger and
olleagues20 did not find any difference in hemodynamic
erformances between the MM (supra-annular) and Peri-
ount (intrasupra-annular) valves if the patient’s annulus,
s measured with a metric sizer, was chosen as the reference
imension. Botzenhardt and associates,8 comparing supra-
nnular tissue valves in a prospective nonrandomized
tudy, indicated the CEM valve as the gold standard in
he panorama of supra-annular tissue valves, stating that
o advantages could be obtained with the other supra-
nnular prostheses in comparison with the standard Peri-
ount valve. These conclusions nevertheless clash with
ur in vitro data.
According to our experimental results, pericardial valve
rostheses exhibited the smallest transprosthetic mean and
eak gradients and the lowest stroke work loss in com-
arison with porcine valves. As previously observed by
uehnel and associates,21 who compared the Carpentier-
dwards-Perimount valve with the MM valve in a mock
ircuit, we observed that the pericardial valve, unlike the
orcine valve, exhibited an EOA flow dependency. This
eans that the porcine valve cusps (mostly for the SJME
alve in our study) were fully open already under low-flow
onditions, showing comparable results to the pericardial
alves at 2 L/min, and therefore the porcine prosthesis does
ot show a CO-dependent effective opening area reserve.
his should be the result of the major pliability of the porcine
issue rather than the pericardial leaflets. Therefore at increas-
ng heart rate, we expect a modification of the performances
f both models. However, to explain this hypothesis, we are
erforming new tests and modifying parameters, such as
eart rate, stroke volume, and systemic resistance.
Among the pericardial bioprostheses, the CEM valve
howed the larger EOA, the lower mean and peak systolic
ressure differences, and the lower stroke work loss at a CO
f 2 and 4 L/min. However, these results were substantially
omparable with those observed with the MF and SS valves,
nd at increasing CO (7 L/min), the MF valve performed a
The Journal of Thoracicignificantly better, exhibiting the largest EOA, the lowest
radients, and the lowest stroke work loss.
Additionally, the MF valve had the lowest total regurgitant
olume and the lowest valve leakage volume, proving that the
esign of this prosthesis, with the pericardium sutured ex-
ernally to the stent, provides an effective opening area
eserve and an adequate central leaflet coaptation. These in
itro results strongly contrast with the conclusions reported
y others.8
Finally, although in small valves the cause of energy loss
s greatly related to the forward flow transvalve pressure
ifference rather than to the regurgitant flow,22 the unex-
ected highest total, closing, and leakage volumes observed
ith the CEM valve might in some way explain the worse
ydrodynamic results of this prosthesis in comparison with
he SS and MF valves at increasing COs. Moreover, the
igh regurgitant volumes observed with the CEM valve
ight be determined on the basis of a limited central leaflet
oaptation, which might explain the lower tolerability of
his valve to annular distortion.18
This is an in vitro study, and therefore the transfer of
hese data to an in vivo situation is limited by the fact that
he in vivo hemodynamic behavior of a valve might differ
rom our idealized assumptions. However, we can consider
hat a good correlation between in vitro and in vivo results
xists because in vitro EOAs tend to overestimate in vivo
OAs by 10% to 15%.23 Moreover, we tested the valves
sing a saline solution with a lower viscosity than blood.
The second limitation is related to the fixed heart rate
elected for all the tests. We mean that it is not realistic to
each a CO of 7 L/min while maintaining a fixed heart rate.
herefore the performance of the pericardial valve, the
eaflets of which are less pliable than porcine valves, might
e overestimated in this in vitro study. We are planning a
ew study design in which we will test the valves, modify-
ng concomitantly several parameters (heart rate, stroke
olume, and systemic resistance). Nevertheless, we retain
his work as important because it could be interpreted as the
rst in vitro comparison of supra-annular prostheses from
hose conclusions new studies might be projected.
Additionally, in vitro comparison of different supra-
nnular bioprostheses according to the true tissue annulus
iameter has not yet been described in the literature to our
nowledge. From our results, it became obvious that the
ericardial valves show higher hemodynamic performances
hen compared with the porcine valves, mostly at higher
Os. Moreover, at increasing COs, the SS valve shows
omparable results to the CEM valve, whereas the MF valve
as the significantly superior prosthesis.
linical Inferences
his study model, which strictly correlates a definite aortic
nnulus of 21 mm to a definite spread of supra-annular
and Cardiovascular Surgery ● Volume 131, Number 5 1063
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Figure E2. Leakage volumes. CE, Carpentier-Edwards.
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